Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Announces NMPA Acceptance Of Biologics License Application For TAB014

June 12 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK:

NMPA ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION FOR TAB014 FOR WET AGE-RELATED MACULAR DEGENERATION TREATMENT

Further company coverage: 6622.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news